Dayspa

NOV 2018

DAYSPA is the business resource for spa & wellness professionals! Each issue covers the latest in skin care, spa treatments, wellness services and management strategies.

Issue link: https://dayspamagazine.epubxp.com/i/1040066

Contents of this Issue

Navigation

Page 67 of 76

dayspamagazine.com • november 2018 • [ 65 ] A study published in the Journal of Investigative Dermatology suggests an acne vaccine could be on the horizon. According to the researchers, acne vulgaris is the result of a skin bacterium called Propionibacterium acnes (P. acnes), which secretes an infl ammatory toxin called Christie-Atkins-Munch-Peterson (CAMP) factor. In the study, the scientists were able to use CAMP factor antibodies to diminish the infl ammatory response in both mice and human skin cultures. The goal of the vaccine would be to educate the immune systems of acne patients, allowing their skin to naturally control the growth of P. acnes. "Once validated by a large- scale clinical trial, the potential impact of our fi ndings is huge for the hundreds of millions of individuals suff ering from acne vulgaris," says lead investigator Eric (Chun- Ming) Huang, PhD, adjunct professor of medicine in the department of dermatology at the University of California, San Diego. "Current treatment options are often not eff ective or tolerable for many of [these individuals]. New, safe and effi cient therapies are sorely needed." Breakout Breakthrough H E A L I N G N E W S Cruelty-Free in California California is set to become the fi rst state to ban the sale of beauty products and ingredients that have been tested on animals. In September, the Cruelty-Free Cosmetics Act (SB 1249) was unanimously passed in the State Assembly and signed into law by Governor Jerry Brown. After January 1, 2020, violators will be subject to an initial fi ne of $5,000 a day, with additional daily fi nes of $1,000 until the violation is resolved. (Exceptions specify that animal testing is allowed if required by the FDA due to a human health concern, or if a regulatory compliance was imposed by a foreign authority—a provision that will expire in January 2023.) © GETTY IMAGES

Articles in this issue

Links on this page

Archives of this issue

view archives of Dayspa - NOV 2018